327 related articles for article (PubMed ID: 15990700)
1. COX-2 inhibitors and metabolism of essential fatty acids.
Das UN
Med Sci Monit; 2005 Jul; 11(7):RA233-7. PubMed ID: 15990700
[TBL] [Abstract][Full Text] [Related]
2. Can COX-2 inhibitor-induced increase in cardiovascular disease risk be modified by essential fatty acids?
Das UN
J Assoc Physicians India; 2005 Jul; 53():623-7. PubMed ID: 16190133
[TBL] [Abstract][Full Text] [Related]
3. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems.
Sharma S; Sharma SC
Indian J Exp Biol; 1997 Oct; 35(10):1025-31. PubMed ID: 9475035
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies.
Tapiero H; Ba GN; Couvreur P; Tew KD
Biomed Pharmacother; 2002 Jul; 56(5):215-22. PubMed ID: 12199620
[TBL] [Abstract][Full Text] [Related]
5. [Specific cyclo-oxygenase-2 inhibitors in cardiovascular pathology].
Monsuez JJ
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):632-40. PubMed ID: 15283037
[TBL] [Abstract][Full Text] [Related]
6. [Biology of essential fatty acids (EFA)].
Dobryniewski J; Szajda SD; Waszkiewicz N; Zwierz K
Przegl Lek; 2007; 64(2):91-9. PubMed ID: 17892040
[TBL] [Abstract][Full Text] [Related]
7. Essential fatty acids: biochemistry, physiology and pathology.
Das UN
Biotechnol J; 2006 Apr; 1(4):420-39. PubMed ID: 16892270
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
Howard PA; Delafontaine P
J Am Coll Cardiol; 2004 Feb; 43(4):519-25. PubMed ID: 14975457
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
Fosslien E
Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252
[TBL] [Abstract][Full Text] [Related]
10. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.
Das UN
Lipids Health Dis; 2008 Oct; 7():37. PubMed ID: 18922179
[TBL] [Abstract][Full Text] [Related]
11. Role of prostacyclin in the cardiovascular response to thromboxane A2.
Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
[TBL] [Abstract][Full Text] [Related]
12. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?
Hersh EV; Lally ET; Moore PA
Curr Med Res Opin; 2005 Aug; 21(8):1217-26. PubMed ID: 16083531
[TBL] [Abstract][Full Text] [Related]
13. Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2.
Levin G; Duffin KL; Obukowicz MG; Hummert SL; Fujiwara H; Needleman P; Raz A
Biochem J; 2002 Jul; 365(Pt 2):489-96. PubMed ID: 11939906
[TBL] [Abstract][Full Text] [Related]
14. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
15. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance.
Poorani R; Bhatt AN; Dwarakanath BS; Das UN
Eur J Pharmacol; 2016 Aug; 785():116-132. PubMed ID: 26335394
[TBL] [Abstract][Full Text] [Related]
16. ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
Sakata C; Kawasaki T; Kato Y; Abe M; Suzuki K; Ohmiya M; Funatsu T; Morita Y; Okada M
Thromb Res; 2013 Jul; 132(1):56-62. PubMed ID: 23522855
[TBL] [Abstract][Full Text] [Related]
17. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
18. Getting to the heart of COX-2 inhibition.
Breyer MD
Cell Metab; 2005 Sep; 2(3):149-50. PubMed ID: 16154096
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
20. "Cell Membrane Theory of Senescence" and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications.
Das UN
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33567774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
